Focused physicochemical stability study of reconstituted trastuzumab biosimilar SB3 (Ontruzant ®) stored in the original vials over 28 days

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Focused physicochemical stability study of reconstituted trastuzumab biosimilar SB3 (Ontruzant ®) stored in the original vials over 28 days ; volume:9 ; number:1 ; year:2024 ; extent:06
Pharmaceutical technology in hospital pharmacy ; 9, Heft 1 (2024) (gesamt 06)

Creator: Knoll, Laura
Thiesen, Judith
Krämer, Irene

DOI: 10.1515/pthp-2024-0001

URN: urn:nbn:de:101:1-2405231543230.689953297078

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Knoll, Laura
Thiesen, Judith
Krämer, Irene

Other Objects (12)

Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties

Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab

Dokument

Vial

Akten

Vial

Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar

Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Personenakte

Vial, Gottlieb

Akte/Dokument

Vial, Alexander

Kapitel

Vial, A.

Kapitel

Vial, A.

Akte/Dokument

Vial, Irmgard

Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties

Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab

Dokument

Vial

Akten

Vial

Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar

Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Personenakte

Vial, Gottlieb

Akte/Dokument

Vial, Alexander

Kapitel

Vial, A.

Kapitel

Vial, A.

Akte/Dokument

Vial, Irmgard

Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties

Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab

Dokument

Vial

Akten

Vial

Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar

Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Personenakte

Vial, Gottlieb

Akte/Dokument

Vial, Alexander

Kapitel

Vial, A.

Kapitel

Vial, A.

Akte/Dokument

Vial, Irmgard

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Focused physicochemical stability study of reconstituted trastuzumab biosimilar SB3 (Ontruzant ®) stored in the original vials over 28 days

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties

Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab

Vial

Vial

Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar

Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Vial, Gottlieb

Vial, Alexander

Vial, A.

Vial, A.

Vial, Irmgard

Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties

Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab

Vial

Vial

Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar

Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Vial, Gottlieb

Vial, Alexander

Vial, A.

Vial, A.

Vial, Irmgard

Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties

Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab

Vial

Vial

Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar

Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab

Vial, Gottlieb

Vial, Alexander

Vial, A.

Vial, A.

Vial, Irmgard

Related objects

Reset password